MarkFloydLewMD
Neurology • Los Angeles, CAMovement Disorder
Professor of Neurology, USC School of Medicine
Dr. Lew is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1520 San Pablo St
Suite 3000
Los Angeles, CA 90033Phone+1 323-442-5710Fax+1 323-442-5729
Education & Training
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Neurology, 1988 - 1991
George Washington UniversityInternship, Internal Medicine, 1987 - 1988- George Washington University School of Medicine and Health SciencesClass of 1987
Certifications & Licensure
CA State Medical License 1988 - 2025- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2011-2014
- Top Doctors:LA Area Castle Connolly, 2013
- Top Doctors:Southern California Castle Connolly, 2012
- Join now to see all
Clinical Trials
- A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation Start of enrollment: 2013 Sep 01
- Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation Start of enrollment: 2017 May 11
Publications & Presentations
PubMed
- 28 citationsMulticenter observational study of abobotulinumtoxinA neurotoxin in cervical dystonia: The ANCHOR-CD registryRichard Trosch, Alberto J. Espay, Daniel D. Truong, Ramon Gil, Carlos Singer
Journal of the Neurological Sciences. 2017-05-15 - 242 citationsThe recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertensionChristopher H. Gibbons, Peter Schmidt, Italo Biaggioni, Camille Frazier-Mills, Roy Freeman
Journal of Neurology. 2017-01-03 - 93 citationsTozadenant (SYN115) in patients with Parkinson's disease who have motor fluctuations on levodopa: a phase 2b, double-blind, randomised trialRobert A. Hauser, C. Warren Olanow, Karl Kieburtz, Emmanuelle Pourcher, Any Docu-Axelerad
The Lancet. Neurology. 2014-08-01
Press Mentions
Protein Content in Tears May Help to Identify People with Parkinson’s Disease, Study SaysAugust 27th, 2018
Tears Can Be Cheapest Biological Markers of Parkinson’s DiseaseMarch 19th, 2018- Tears May Be Used as Biological Marker to Detect Parkinson’s DiseaseMarch 1st, 2018
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
